TRINITY BIOTECH PLC
For the period ended Jul 22, 2026. Filed Jul 22, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Jul 22, 2026 · Filed Jul 22, 2026
Use the contents to explore the available documents and sections.
TRIB$5.70-3.3%Stored close · as of Nov 6, 2026
Contents
EXPLANATORY NOTE
On July 22, 2026, the Company announced a strategic collaboration in Latch Medical Limited to develop biosensor-guided precision drug delivery solutions using CGM+ technology. A copy of the press release is being furnished herewith as Exhibit 99.1.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.